Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/6232
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarrison, Margo S-
dc.contributor.authorMabeya, Hillary-
dc.contributor.authorGoldenberg, Robert L-
dc.contributor.authorMcClure, Elizabeth M-
dc.date.accessioned2022-04-11T09:42:48Z-
dc.date.available2022-04-11T09:42:48Z-
dc.date.issued2015-08-19-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/6232-
dc.description.abstractBackground: While obstetric fistula has been recognized as a major maternal morbidity since the 1980s, it has become an indicator of access to and quality of women’ s health care. Findings: Obstetric fistula still exists in low-income countries (LIC) because health care systems fail to provide adequate family planning, skilled birth attendance, basic and emergency obstetric care, and affordable treatment of fistula, while concurrently lacking social networks to serve as safety nets for affected girls and women [WHO, 2007]. Conclusion: This review explores the most recent published experience with respect to the definition of fistula, its diagnosis, treatment, and management, and further steps for prevention of fistula on a global scale.en_US
dc.language.isoenen_US
dc.publisherBiomed centralen_US
dc.subjectUrogenital fistulaen_US
dc.subjectObstetric fistulaen_US
dc.subjectMaternal morbidityen_US
dc.subjectLow and middle income countriesen_US
dc.titleUrogenital fistula reviewed: a marker of severe maternal morbidity and an indicator of the quality of maternal health care deliveryen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
MABEYA.pdf478.56 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.